Quest Diagnostics
793 hedge funds and large institutions have $12B invested in Quest Diagnostics in 2023 Q3 according to their latest regulatory filings, with 70 funds opening new positions, 230 increasing their positions, 336 reducing their positions, and 81 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
14% less capital invested
Capital invested by funds: $14B → $12B (-$1.98B)
32% less repeat investments, than reductions
Existing positions increased: 230 | Existing positions reduced: 336
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
793
Holding in Top 10
1
Calls
$132M
Puts
$39.7M
Top Buyers
| 1 | +$83M | |
| 2 | +$65.6M | |
| 3 | +$47.3M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$40.7M |
| 5 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
+$39.4M |
Top Sellers
| 1 | -$137M | |
| 2 | -$74.4M | |
| 3 | -$64.5M | |
| 4 |
BlackRock
New York
|
-$43.4M |
| 5 |
Amundi
Paris,
France
|
-$37.2M |